等待开盘 11-19 09:30:00 美东时间
-0.170
-3.64%
11月17日,CorMedix Inc(CRMD)收涨3.43%,报4.82美元,成交额1571.64万美元,市值3.83亿美元。 行情数据 • 开盘价:5....
11-17 07:13
华盛资讯11月16日讯,CorMedix公布2026财年Q3业绩,公司Q3营收0.55亿美元,同比下降47.7%,归母净利润亏损0.15亿美元,由盈转亏。
11-16 23:16
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从39美元升至40美元;HC Wainwright & Co.:维持Fractyl Health"买入"评级,目标价从8美元升至24美元
11-16 20:14
最新财报显示,CorMedix Inc 2026财年第3季度实现: 营业收入:5451.9万美元 同比:下降47.72% 净利润:-1472.2万美元 同比:下...
11-14 21:00
Cormedix (NASDAQ:CRMD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/ap...
11-12 22:13
华盛资讯11月12日讯,CorMedix公布2026财年Q3业绩,公司Q3营收0.55亿美元,同比下降47.7%,归母净利润亏损0.15亿美元,由盈转亏。
11-12 21:31
华盛资讯11月12日讯,CorMedix公布2026财年Q3业绩,公司Q3营收0.55亿美元,同比下降47.7%,归母净利润亏损0.15亿美元,由盈转亏。
11-12 21:18
Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.10) by 90 percent. This is a 133.33 percent decrease over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $54.519 million which...
11-12 20:42
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
11月10日,CorMedix Inc(CRMD)收涨2.82%,报5.47美元,成交额1262.68万美元,市值4.26亿美元。 行情数据 • 开盘价:5....
11-10 07:13